Caxton Associates (New York)’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-11,637
Closed -$122K 646
2024
Q3
$122K Buy
+11,637
New +$122K ﹤0.01% 501